4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-20-045142
President and CSO sold 6,200 shares at an average $20.02 ($124,114)
- President and CSO acquired 6,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Suri Anish President and CSO | 2020-08-03 | Option exercise | +2,000 | $8.26 | $16,520 | 36,558 | D |
| Suri Anish President and CSO | 2020-08-03 | Option exercise | +3,800 | $6.42 | $24,396 | 40,358 | D |
| Suri Anish President and CSO | 2020-08-03 | Sale | −5,800 | $20.01 | $116,058 | 34,558 | D |
| Suri Anish President and CSO | 2020-08-04 | Option exercise | +400 | $6.42 | $2,568 | 34,958 | D |
| Suri Anish President and CSO | 2020-08-04 | Sale | −400 | $20.14 | $8,056 | 34,558 | D |
| Derivatives | |||||||
| Suri Anish President and CSO | 2020-08-03 | Option exercise · Stock Option (right to buy) | −2,000 | 18,000 | D | ||
| Suri Anish President and CSO | 2020-08-03 | Option exercise · Stock Option (right to buy) | −3,800 | 146,200 | D | ||
| Suri Anish President and CSO | 2020-08-04 | Option exercise · Stock Option (right to buy) | −400 | 145,800 | D | ||
| Open-market sales · 6,200 sh · avg $20.02 · $124,114 | |||||||
Loading xslF345X03/doc4.xml…